
zzso zzso zzso is an aggressive zzso with limited treatment zzso The zzso zzso zzso and zzso of zzso zzso zzso zzso plays a key role in promoting zzso in zzso Recently a new zzso inhibitor zzso zzso has been developed by Novartis zzso and it shows high affinity for zzso zzso with very low affinity for zzso zzso Clinical trials have demonstrated that zzso has good therapeutic efficacy for the treatment of zzso and is currently zzso approved for the treatment of advanced stages of this zzso Our study tested the effects of zzso on zzso zzso in zzso zzso effectively inhibited zzso zzso in zzso cells with a significant reduction in the expression of zzso downstream targets zzso and zzso zzso also caused a marked reduction in the proliferation and colony formation of zzso zzso The zzso effect of zzso on zzso cells is unlikely due to zzso effects with no zzso of key regulators of other cell zzso zzso To our knowledge this study is the first to report on the effect of zzso on liver cancer zzso 

